UK markets open in 1 hour 38 minutes

Reneo Pharmaceuticals, Inc. (RPHM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.70000.0000 (0.00%)
At close: 04:00PM EDT
1.7000 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 56.82M
Enterprise value -25.11M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.70
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.16

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-80.96%
S&P500 52-week change 324.52%
52-week high 39.3000
52-week low 30.9800
50-day moving average 31.7119
200-day moving average 33.8497

Share statistics

Avg vol (3-month) 3255.5k
Avg vol (10-day) 388.38k
Shares outstanding 533.42M
Implied shares outstanding 633.42M
Float 88.97M
% held by insiders 15.14%
% held by institutions 189.74%
Shares short (15 May 2024) 43.63M
Short ratio (15 May 2024) 47.73
Short % of float (15 May 2024) 418.76%
Short % of shares outstanding (15 May 2024) 410.86%
Shares short (prior month 15 Apr 2024) 42.94M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-51.66%
Return on equity (ttm)-84.01%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -75.7M
Net income avi to common (ttm)-70.71M
Diluted EPS (ttm)-2.1700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)82.83M
Total cash per share (mrq)2.48
Total debt (mrq)907k
Total debt/equity (mrq)1.12%
Current ratio (mrq)29.83
Book value per share (mrq)2.43

Cash flow statement

Operating cash flow (ttm)-75.65M
Levered free cash flow (ttm)-47.77M